News

Photo
31.10.2025 • News

Anne-Kathrin Stoller Becomes New CEO at Bachem

Bachem's Board of Directors has appointed Anne-Kathrin Stoller, the former Head of Bachem Americas and previously the company's CMO for many years, as the new CEO effective January 1, 2026.

Photo
06.10.2025 • NewsChemistry

Syensqo Announces CEO Transition

Syensqo has announced that Ilham Kadri will step down as CEO on January 1, 2026, with Mike Radossich, current President of Performance & Care, set to assume the role and lead the company into its next growth phase.

13782 more News

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.